jridley17 - Divvy is solid since Walt & wife own half of the common. Therefore, about 8 mil shrs * 0.2/shr = $1.6 million per year. This divvy will stay. Further, re company future rev growth & earnings, look for synergism with the newly acquired Cognigen company as fuel. Also, do not overlook the large potential of software use in defense industry (they are presenting at defense oriented conferences now) and the value of the malaria & COX2 inhibitor successes! If you have not yet listened to the quarterly conf calls, suggest that you do.
This sentence from the 4th quarter report bodes well for the future: "In the near term we intend to leverage the strength of our financial performance by continuing to invest in promotional expenditures with the goal of expanding our market share in several domestic markets in a profitable way.”
This is an excerpt from the Qtly report citing Walt's comment: "...enabling me to increase my focus on products, services, and business development. I am particularly excited about two new products under development for use in the aerospace and healthcare industries. These products use our artificial neural network ensemble modeling engine and we intend to pursue customers and funding to develop customized tools and applications.”
Anyone here interested in the company having an earnings conference call? I've sent an email suggesting that to the company but haven't yet received a reply. Other small cap companies have CCs (example is SLP) and I find them invaluable in keeping abreast of the company's goings on. Also allows small investors like ourselves to ask questions real time. Appreciate your comments.